PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “GINGIVAL HYPERPLASIA”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 487 records · Page 27Linked to original sources
PubMed1996

Clinical assessment of periodontal conditions in patients treated with nifedipine.

Calcium antagonists are widely used in treating acute and chronic coronary insufficiency disorders. A major side effect of long-term treatment is gingival hyperplasia. In the present study, 70 patients taking nifedipine for at least six months and 70 controls similar in age, gender, approximal hygiene and systemic disease with at least 6 anterior teeth in upper and lower arches were examined. Their periodontal conditions were determined by modified Sulcus-Bleeding-Index (mSBI), modified Approximal-Plaque-Index (mAPI), Community Periodontal Index of Treatment Needs (CPITN), a hyperplasia index quantifying the extent of gingival overgrowth, probing depths, clinical attachment loss and the modified Phenytoin-Gingival-Inflammation-Index (mPGI). A mild to moderate gingival hyperplasia was diagnosed in 21 of 70 patients resulting in a prevalence of 30% compared to 8.5% in controls. The hyperplastic changes were situated mainly in the anterior region of the dentition. Significant differences between both groups could be found comparing the severity of the gingival hyperplasia, the CPITN, mSBI, probing depths and the part of mPGI evaluating colour and turgor of the gingiva (p < 0.05). The severity of gingival overgrowth was strongly correlated with the inflammatory gingival changes, probing depths, the periodontal treatment need and the approximal hygiene of the patients. No statistically significant correlation could be found between the severity of gingival hyperplasia and the age and gender of the patient, or the dose or duration of nifedipine therapy. Gingival changes seemed to be more pronounced in patients with cardiovascular disorders than in patients under hemodialysis. The high incidence of gingival hyperplasia in patients receiving nifedipine on a long-term basis emphasises the role of the dentist and general practitioner in the early detection and prophylaxis of gingival changes and requires a thorough information to the patient concerning periodontal side effects.

Bicuspid↗
PubMed1991

[Side effects of the immunsuppressive cyclosporin A in dentistry].

31 renal transplant patients with Cyclosporin-A-Medication were dental discussed. Half of the patients showed gingival hyperplasia in the anterior region of the maxilla after different time of medication. A relation between gingival hyperplasia, age and sex could'nt be seen. Two stomatitis were presented. The oral hygiene and the parodontal statement before the transplantation influenced the formation of gingival hyperplasia. At time it seems, that Nifedipin has no influence on the formation of gingival hyperplasia. We recommend a extensive research with a long list of patients. A patient with a voluminous hyperplasia was discussed.

Adult↗
PubMed2001

Oral manifestations in patients with aplastic anemia.

OBJECTIVE: The aim of the present study was to characterize the prevalence and risks of oral complications in aplastic anemia (AA). STUDY DESIGN: Approximately 79 patients with AA (age, 37 +/- 17 years) and 66 control patients with schizophrenia (age, 33 +/- 12 years) were examined. Records were reviewed for demographic, clinical, and radiographic information. Prior medical therapy, laboratory values, disease duration, and medical treatment response were noted for patients with AA. Odds ratios (OR) and 95% CI were calculated for oral manifestations in cases and in control subjects. Univariate analysis identified important variables for logistic regression. RESULTS: Patients with AA presented more frequently with oral petechiae (OR = 49; 95% CI, 2.9-825), gingival hyperplasia (OR = 27; 95% CI, 1.6-463.5), spontaneous gingival bleeding (OR = 27; 95% CI, 1.6-463.5), and herpetic lesions (OR = 27; 95% CI, 1.6-463.5). Prior cyclosporine use was associated with gingival hyperplasia (P =.0001). No other predictors for oral manifestations or treatment outcomes were found. CONCLUSIONS: Oral soft tissue changes and infections were more common in patients with AA. Prior cyclosporine use was predictive of the presence of gingival hyperplasia.

Adult↗
PubMed2002

Nifedipine induces gingival epithelial hyperplasia in rats through inhibition of apoptosis.

BACKGROUND: Nifedipine is used as a long-acting vasodilator; one of its side effects is gingival overgrowth, characterized by an accumulation of collagenous components within the gingival connective tissue and epithelial hyperplasia with elongated, branched rete pegs penetrating into the connective tissue. We investigated the effect of nifedipine on apoptosis of gingival keratinocytes of rats to elucidate the mechanism of nifedipine-induced gingival epithelial hyperplasia. METHODS: Twenty-day-old rats were fed a powdered diet containing or lacking nifedipine for 8 to 30 days. The mandibular gingiva and palatal mucosa were removed on days 8, 15, or 30, and epithelial thickness was examined by light microscopy. In situ terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay was used to examine apoptosis of keratinocytes in the epithelium. In addition, we examined the effects of nifedipine on proliferation of keratinocytes and epithelial cell life on day 8 by 5-bromo-2'-deoxyuridine (BrdU) staining. RESULTS: Microscopic examination showed gingival epithelial hyperplasia in nifedipine-treated rats after day 15. Apoptosis of gingival keratinocytes was seen to be inhibited in nifedipine-treated rats on day 8 and 15. Also, nifedipine did not induce an increase of keratinocyte proliferation activity in terms of the number of cells showing positive staining with BrdU. Prolongation of cell life by nifedipine was observed on day 8 in gingival epithelium through a delay of upward cell movement compared to controls. However, epithelial hyperplasia was not detected in palatal mucosa, and there were no significant differences in apoptotic rates of keratinocytes and cell life between nifedipine-treated rats and control rats. CONCLUSIONS: These results suggest that nifedipine induces epithelial hyperplasia in gingival overgrowth not by an increase in keratinocyte proliferation, but by prolongation of cell life through reduction of apoptosis before epithelial hyperplasia is detectable.

Animals↗
PubMed2004

Severe gingival bleeding in a myelodysplastic patient: management and outcome.

BACKGROUND: The myelodysplastic syndromes (MDS) are a group of stem cell disorders characterized by a reduction in one or more elements of the peripheral blood. Oral manifestations of the disease and oral complications of medical management may result in significant symptoms and have an impact on the systemic condition of the patient. The removal of the infectious focus, such active teeth infection or severe periodontal disease, remains controversial in these patients, due to the increased risk of bleeding and systemic infection. METHODS: This paper reports a case of MDS with spontaneous gingival hemorrhage and generalized gingival hyperplasia associated with periodontal disease. This patient underwent several platelet transfusions due to these oral complications. The patient received periodontal therapy, resulting in an improvement of the oral clinical situation and a decrease of gingival hyperplasia. RESULTS: The patient did not present any episode of gingival hemorrhage after the periodontal treatment. CONCLUSION: The results of this study suggest that periodontal therapy should be performed in MDS patients presenting thrombocytopenia, gingival hyperplasia, and gingival bleeding, with the intent of preventing further hemorrhagic episodes and possible systemic infection.

Adult↗
PubMed1986

Clinical crown length and reduction in overjet, overbite, and dental height with orthodontic treatment.

To evaluate the clinical crown length relative to fixed-appliance orthodontic treatment of excessive overjet and deep overbite and to correlate such changes to the vertical dental height, the following measurements were undertaken for 12 females and 8 males, between the ages of 16 and 20 years, on three separate occasions--2 days before banding, 2 days after debanding, and 12 months after debanding: (1) overjet, overbite and dental height measured from right lateral cephalometric x-ray films; (2) clinical crown length, measured from study models, of 400 teeth divided into four groups--maxillary incisors and canines (120 teeth), maxillary second premolars and first molars (80 teeth), mandibular incisors and canines (120 teeth) and mandibular second premolars and first molars (80 teeth); and (3) gingival condition by means of the gingival index of Löe and Silness. Fixed edgewise orthodontic appliances were used and the four first premolars were extracted. From the results of the investigation, the following conclusions were evident: after a 12-month follow-up observation period, the achieved reduction in overjet, overbite, and dental height showed relapses of 9%, 11%, and 29%, successively; only 7% of the 400 teeth examined showed reductions in clinical crown length. This change was probably the result of gingival hyperplasia. The gingival condition greatly improved by approximately 64% after 12 months of debanding, accompanied by 25% to 50% relapse in the amount of change in clinical crown length (noted 2 days after debanding); and the intrusive tooth movement during orthodontic correction of deep overbite was the result of vertical movement of the tooth, with its investing tissues and soft-tissue attachment, into the jaws.(ABSTRACT TRUNCATED AT 250 WORDS)

Adolescent↗
PubMed1985

[Hypertrophic gingivitis caused by verapamil].

We observed gingival hyperplasia, similar clinically to the hyperplasia caused by diphenylhydantoin during the last 11 months in two patients treated by verapamil, suffering from angina pectoris pains. In Case I discontinuation of the calcium antagonist resulted in marked regression of the gingival hyperplasia. Evidence points to a strong relationship between the gingival hyperplasia and the administration of verapamil. Further studies are required to confirm definitively the relationship between the administration of verapamil and gingival hyperplasia, its incidence, and the correlation with local factors.

Angina Pectoris↗
PubMed1995

[Stimulation of platelet mitogen-induced prostaglandin I2 synthesis in periodontal tissue of cyclosporin A treated patients].

Cyclosporine A (CsA) is a highly potent immunosuppressive agent that has proven to be particularly useful in organ transplantation. Like phenytoin and the calcium antagonists, this drug may be associated with gingival hyperplasia. This study examined the interaction of platelet derived growth factor (PDGF) with prostaglandin I2 (PGI2)--a potent mediator in inflammation and bone resorption. PGI2 synthesis was examined by bioassay in gingival tissue from rats, rabbits and humans. Gingival tissue from CsA-treated patients generates less PGI2. PDGF causes a dose-dependent increase in PGI2 release in both CsA-treated and control subjects. The actual and percentage increase in PGI2 synthesis, however, was significantly higher in control tissue. While PDGF on the other hand modulated cellular proliferation, it causes on the other hand liberation of PGI2 from gingival tissue, thus interfering with its own action and further synthesis. If the PGI2 response is insufficient as after CsA therapy, the proliferative action might dominate. These findings therefore suggest an important pathogenetic role of PDGF and possibly other growth factors in CsA-induced gingival hyperplasia. "CsA gingivitis" seems to be a predominantly proliferative process, whereby inflammatory reactions appear only as a secondary phenomenon.

Adult↗
PubMed1976

[Changes in the mouth mucosa during pregnancy and hormonal contraceptive treatment].

The oral mucous membrane, especially the gingiva, may undergo changes during pregnancy which, from clinical and histological observations, should be termed pregnancy gingival hyperplasia. Such rare cases of hyperplasia mimic pregnancy gingival tumours (granuloma gravidarum) within the buccal cavity. The gingival changes observed occasionally in women taking oral contraceptives may also be due to hormonal causes.

Adult↗
PubMed1998

[The importance of periodontal evaluation in orthodontics].

The orthodontist is in fact a periodontal-therapist since his aim is to move the teeth with and through the periodontal tissues. It is most important for the orthodontist to be able to determine at the initial clinical examination what are the various periodontal risk factors. When the pathology is obvious with inflammation, periodontal pockets, gingival hyperplasia, edema of the papillae, gingival recessions, the need for periodontal treatment is manifest. But many times, the periodontal evaluation is complicated by the presence of slight variations of the quality of the marginal tissue that represent a risk of developing periodontal defects during the orthodontic treatment. The aim of this presentation is to put forward the importance of the periodontal evaluation during the initial examination of the patient so that, if necessary, an adequate periodontal therapy can be initiated to stabilize the periodontal tissues and thus improves the esthetical outcome.

Dental Plaque↗
PubMed1993

The effect of cyclosporin-A on the ultrastructure of gingival tissue in Behçet's disease.

Autoimmune processes are said to play an active role in aetiology of Behçet's disease (BD), which is also known as a multisystem disease. In the treatment of this autoimmune disease, cyclosporin A (CyA) is used. Gingival hyperplasia (GH) is one of the important side effects that have been observed in some of the patients. We aimed to evaluate the CyA-induced gingival hyperplasia in BD patients. There were 3 study groups, each having 5 patients. In the first group displaying GH, mast cells were located between epithelial cells and in the connective tissue. Mast cell granules were in crystalline form and electron-dense cored form. Fibroblasts and plasma cells were present in the connective tissue. The second group did not display GH and the mast cells were similar to those in the first group. The third group, was the control group, in which the mast cells were located between the epithelial cells and connective tissue. Mast cell granules were in electron-dense cored form. We concluded that the development of CyA-induced gingival hyperplasia is determined mainly by individual sensitivity to CyA, because although both test groups which received CyA showed an increased number and activity of fibroblasts, only one group of patients developed GH.

Adolescent↗
PubMed1987

Effect of folate on phenytoin hyperplasia.

There have been some reports that folic acid inhibits phenytoin-induced gingival hyperplasia. The purpose of this double-blind study was to quantify clinically the effects of both systemic and topical administration of folic acid on phenytoin-induced gingival overgrowth in man. For a period of 6 months, one group of phenytoin patients received 2 daily topical applications of a folate solution. An additional group received 2 daily doses of systemic folate while a control group received placebo medication. Results indicate that throughout the 180-day period of the study, the topical folate significantly inhibited gingival hyperplasia to a greater extent than either systemic folate or placebo groups.

Administration, Oral↗
PubMed1987

The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. A longitudinal study.

The periodontal health of 24 adult renal transplant patients was investigated in a longitudinal study. Post-transplant patients were receiving either azathioprine or cyclosporin to prevent graft rejection. No significant difference (P greater than 0.05) was observed for plaque scores on gingival inflammation, either between treatment groups or throughout the investigation period. However, patients on cyclosporin therapy had significantly more gingival hyperplasia and probing sites greater than 3 mm than those on azathioprine (P less than 0.05). In the cyclosporin group, a significant increase in hyperplasia and probing sites greater than 3 mm was observed at 3 and 6 months post-transplant. A significant correlation (rs = 0.55, P less than 0.05) was observed between mean plasma concentrations of cyclosporin throughout the 6-month investigation period and the increase in gingival hyperplasia. The finding from this study would suggest that azathioprine has no unwanted effects on the periodontal health of post-renal transplant patients. Cyclosporin therapy caused an increase in gingival hyperplasia, which may be related to plasma concentrations of the drug.

Adult↗
PubMed2006

Influence of Cyclosporin A on human gingival keratinocytes in vitro.

PURPOSE: Gingival hyperplasia is a well known side effect of Cyclosporine A therapy. The aetiology of this is not totally understood and there is debate whether it is hyperplasia of the gingival epithelium or of the submucosal connective tissue, or both, and what roles play factors like age and gender of the patients, duration and dosage of the drug. MATERIAL AND METHODS: The influence of different Cyclosporine A concentrations (10(-6) g/ml; 5 x 10(-7) g/ml; 10(-9) g/ml) and of no medication (controls) on growth and proliferation of cultured human gingival keratinocytes was investigated after a culture period of 3, 6 and 9 days. Cell proliferation was assessed by counting anti Ki-67 stained nuclei, cell growth by counting total number of nuclei and by the EZ4U-assay. RESULTS: There was no significant correlation of the cell proliferation rate and cellular growth with either gender (p > 0.568) or duration of medication (p > 0.876); but Cyclosporine A concentration showed a highly significant influence on cellular growth (p = 0.0001). Inhibition of cell growth was dependent on drug dosage, but a low concentration of 10(-9) g/ml even stimulated cell growth. CONCLUSIONS: There is evidence that Cyclosporine A in low concentrations (10(-9) g/ml as applied in long-term therapy) stimulates gingival keratinocyte growth and therefore might be related to hyperplasia of the gingiva. However, high Cyclosporine A concentrations may inhibit cell growths and factors like gender of the patient did not show any influence in-vitro.

Adolescent↗